Coupling the immunomodulatory properties of the HDAC6 inhibitor ACY241 with Oxaliplatin promotes robust anti-tumor response in non-small cell lung cancer-Reference-Cited by-同舟云学术

Coupling the immunomodulatory properties of the HDAC6 inhibitor ACY241 with Oxaliplatin promotes robust anti-tumor response in non-small cell lung cancer

Published:2022-02-22 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Bag Arup¹,Schultz Andrew¹,Bhimani Saloni¹,Stringfield Olya²,Dominguez William³,Mo Qianxing⁴,Cen Ling⁴,Adeegbe Dennis¹

Affiliation:

1. Department of Immunology, H. Lee. Moffitt Cancer Center, Tampa, Florida, USA

2. Department of Thoracic Oncology, H. Lee. Moffitt Cancer Center, Tampa, FL, USA

3. Small Animal Imaging Lab, H. Lee. Moffitt Cancer Center, Tampa, FL, USA

4. Department of Biostatistics and Bioinformatics, H. Lee. Moffitt Cancer Center, Tampa, FL, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2042065

Reference50 articles.

1. Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes

2. Histone Deacetylase Inhibitors in Cancer Therapy

3. HDACs and HDAC Inhibitors in Cancer Development and Therapy

4. Panobinostat Approved for Multiple Myeloma

5. Treatment options for relapsed and refractory multiple myeloma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-associated macrophages affect the treatment of lung cancer;Heliyon;2024-04

2. Unraveling the immune landscape and therapeutic biomarker PMEPA1 for oxaliplatin resistance in colorectal cancer: A comprehensive approach;Biochemical Pharmacology;2024-04

3. Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy;Frontiers in Immunology;2023-11-13

4. Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: Structure, function and design;Bioorganic Chemistry;2023-09

5. Trial watch: chemotherapy-induced immunogenic cell death in oncology;OncoImmunology;2023-06-03